(Q50546374)

15 March 2018

title

Phase-1 trial of high-dose intravenous cisplatin with simultaneous intravenous sodium thiosulfate. (English)

1 reference

15 March 2018

main subject

phase I clinical trial

0 references

1 reference

M Markman

1

1 reference

15 March 2018

R D'Acquisto

2

1 reference

15 March 2018

N Iannotti

3

1 reference

15 March 2018

M Kris

4

1 reference

15 March 2018

T Hakes

5

1 reference

15 March 2018

D Bajorin

6

1 reference

15 March 2018

G Bosl

7

1 reference

15 March 2018

B Reichman

8

1 reference

15 March 2018

E Casper

9

1 reference

15 March 2018

G Magill

10

1 reference

15 March 2018

publication date

1 January 1991

1 reference

15 March 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

15 March 2018

volume

117

1 reference

15 March 2018

issue

2

1 reference

15 March 2018

page(s)

151-155

1 reference

15 March 2018

https://scigraph.springernature.com/pub.10.1007/bf01613139

exact match

0 references

cites work

"Two-route chemotherapy" using high-dose ip cisplatin and iv sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice

1 reference

12 December 2020

Effect of sodium thiosulfate on cis-dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia

1 reference

12 December 2020

Selective protection against cis-diamminedichloroplatinum(II)-induced toxicity in kidney, gut, and bone marrow by diethyldithiocarbamate

1 reference

12 December 2020

High-dose cisplatin in hypertonic saline: reduced toxicity of a modified dose schedule and correlation with plasma pharmacokinetics. A Northern California Oncology Group Pilot Study in non-small-cell lung cancer

1 reference

12 December 2020

Phase I trial of escalating doses of cisplatin in hypertonic saline

1 reference

12 December 2020

cis-Platinum in gynecologic cancer. III. Toxicity

1 reference

12 December 2020

WR-2721 and high-dose cisplatin: an active combination in the treatment of metastatic melanoma.

1 reference

12 December 2020

Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies.

1 reference

12 December 2020

Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.

1 reference

12 December 2020

Nitrite and thiosulfate therapy in cyanide poisoning

1 reference

12 December 2020

Effect of sodium thiosulfate on the pharmacokinetics and toxicity of cisplatin

1 reference

12 December 2020

Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer a southwest oncology group study

1 reference

12 December 2020

Dose intensity analysis of chemotherapy regimens in ovarian carcinoma

1 reference

12 December 2020

Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules

1 reference

12 December 2020

Sodium thiosulfate fails to increase the therapeutic index of intravenously administered cis-diamminedichloroplatinum (II) in mice bearing murine and human tumors

1 reference

12 December 2020

Intraperitoneal chemotherapy in the management of ovarian cancer

1 reference

12 December 2020

Kinetics of sodium thiosulfate, a cisplatin neutralizer

1 reference

12 December 2020

High-Dose Cisplatin in Hypertonic Saline

1 reference

12 December 2020

Renal and electrolyte disturbances associated with cisplatin

1 reference

12 December 2020

High-dose cisplatin with sodium thiosulfate protection.

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Intraperitoneal cisplatin with systemic thiosulfate protection

1 reference

12 December 2020

Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activity

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01613139

1 reference

15 March 2018

PubMed ID

2007612

1 reference

15 March 2018